Fertility Preservation on TRT
hCG, Low-Dose hMG/FSH, and Enclomiphene as a Sparing Alternative
Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- hCG is FDA-approved for hypogonadotropic hypogonadism; enclomiphene/clomiphene use for male fertility is off-label
Reference only. Not medical advice.
What can go wrong
Standard suppressive TRT can cause prolonged or, uncommonly, persistent infertility, especially after years of use or in men with pre-existing low sperm production. hCG carries risks of gynecomastia and elevated estradiol; SERMs can cause visual disturbances, mood effects, and (clomiphene more than enclomiphene) a less favorable isomer profile. None of these adjunct uses for male fertility are FDA-approved by indication, and recovery timelines are variable and not guaranteed.
This is something to take to a clinician. The Atlas can tell you what is known about fertility preservation on trt in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Exogenous testosterone suppresses pituitary LH and FSH, which shuts down intratesticular testosterone production and spermatogenesis; azoospermia or severe oligospermia is common within months and is the chief reason fertility-minded men should not start standard TRT uncounseled. Two practical strategies exist: co-administer hCG (an LH analog) and sometimes low-dose hMG/recombinant FSH to keep the testes stimulated during testosterone therapy, or avoid suppressive testosterone entirely and use a SERM such as enclomiphene or clomiphene, which raise the man's own LH/FSH and testosterone while preserving spermatogenesis. Recovery after stopping TRT is usually possible but slow and not guaranteed.
Standard TRT can render a man infertile within months, and many starting it are never told.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
How it is supposed to work
Spermatogenesis depends on high intratesticular testosterone driven by LH and on FSH signaling to Sertoli cells. Exogenous testosterone replaces serum testosterone but suppresses pituitary gonadotropins, collapsing intratesticular testosterone to a fraction of what sperm production needs. hCG binds the LH receptor on Leydig cells, restoring intratesticular testosterone; adding hMG or recombinant FSH supplies the FSH signal. Enclomiphene (the trans-isomer of clomiphene) blocks estrogen feedback at the hypothalamus/pituitary, raising endogenous LH/FSH and testosterone while leaving the testes working, a fundamentally fertility-sparing mechanism rather than a rescue add-on.
Why a normal blood testosterone says nothing about fertility on TRT
Serum testosterone on TRT can look perfect while intratesticular testosterone, the concentration that actually drives sperm production, normally many-fold higher than serum, has collapsed. That is why a man can feel well, have a 'great' lab number, and be azoospermic at the same time. hCG specifically restores the intratesticular compartment; simply lowering or smoothing the testosterone dose does not.
Safety in detail
This intervention involves significant physiological effects and requires evaluation and monitoring by a qualified physician. Self-administration without medical oversight carries documented health risks. Men who wish to preserve fertility should be counseled before starting any suppressive testosterone therapy.
What it does to fertility
This entry IS the fertility-impact topic: standard TRT suppresses spermatogenesis and commonly causes azoospermia; hCG with or without FSH can preserve it during therapy, and enclomiphene/clomiphene raise testosterone while sparing fertility entirely. Baseline and follow-up semen analysis is advised when fertility matters.
What has to be monitored
The bloodwork this needs, and the reason it belongs with a clinician rather than a website.
- Baseline and follow-up semen analysis when fertility is a goal
- LH, FSH at baseline
- Total testosterone and estradiol (especially on hCG)
- Symptom and visual-change review on SERMs
What people get wrong
Often saidTRT is reversible, so fertility always comes back after stopping
ActuallyRecovery is usual but slow (often 6-24 months) and not guaranteed; longer use and pre-existing impairment worsen the odds.
Often saidA normal testosterone level on TRT means fertility is fine
ActuallySerum testosterone and intratesticular testosterone are decoupled on TRT; men with normal serum levels can be azoospermic.
Often saidhCG with TRT guarantees fertility
ActuallyhCG substantially improves the odds of preserving sperm production but does not guarantee it; FSH support and individual variation matter.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
What we do not know
- Optimal hCG (and FSH) dosing to preserve fertility on TRT
- Which men fail to recover spermatogenesis and why
- How enclomiphene's long-term efficacy and safety compare to TRT-plus-hCG
At a glance
- Why TRT suppresses fertility
- Negative feedback shuts off LH/FSH and intratesticular testosterone
- Time to azoospermia
- Often within ~3-6 months
- hCG role
- Mimics LH; maintains intratesticular testosterone/spermatogenesis
- FSH role (hMG/recombinant)
- Supports Sertoli-cell/sperm output; added in some protocols
- Fertility-sparing alternative
- Enclomiphene/clomiphene (SERM) instead of suppressive T
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Fertility Preservation on TRT. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- Where we land. We have not taken a position on this yet.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Coviello et al. on intratesticular testosterone and spermatogenesis (JCEM)2005
Demonstrated the dependence of spermatogenesis on high intratesticular testosterone
Hsieh et al. on testosterone plus hCG preserving semen parameters (J Urol)2013
Concomitant low-dose hCG maintained semen parameters in men on testosterone therapy
Wenker et al. on TRT discontinuation and SERM/hCG for recovery (J Sex Med)2015
Described use of clomiphene/hCG to recover spermatogenesis after exogenous testosterone